DRO321
Monografia
4435
EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION - EMCDDA
Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs / European Monitoring Centre for Drugs and Drug Addiction.- Luxembourg : Office for Official Publications of the European Communities, 2002.- 92 p. ; 21 cm. - (Implemention of the joint action ; 4)
Informação sobre European Monitoring Centre for Drugs and Drug Addiction pode ser encontrada no site: http://www.emcdda.org
ISBN 92-9168-122-9 (Broch.) : oferta
DROGA, DROGAS ILICITAS, SUBSTÂNCIAS PSICOTRÓPICAS, COOPERAÇÃO INTERNACIONAL, SAÚDE PÚBLICA, RELATÓRIO, ESTATISTICAS, EUROPOL, CONSELHO DA EUROPA
Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs. Europol-EMCDDS progress report on GHB in accordance with Article 3 of the joint action of 16 June 1997 concerning the information exchange, risk assessment and the control of new synthetic drugs. Use of GHB as a medicinal product (EMEA). Review of the pharmacotoxicological data on gamma-hydroxybutyric acid (GHB). Sociological and criminological (Europol) evidence on the risk of GHB. Public health risk of GHB - epidemiological evidence.